UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 19, 2012
WINNER MEDICAL GROUP INC.
(Exact Name of Registrant as Specified in its Charter)
| Nevada | | 001-34484 | | 33-0215298 |
| (State or other jurisdiction of incorporation or organization) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
Winner Industrial Park, Bulong Road
Longhua, Shenzhen City, 518109
The People’s Republic of China
(Address of principal executive offices, including zip code)
(86) 755 2813-8888
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.07 | Submission of Matters to a Vote of Security Holders |
The 2012 annual meeting of stockholders of Winner Medical Group Inc. (the “Company”) was held on Thursday, April 19, 2012 at Winner Industrial Park, Bulong Road, Longhua, Shenzhen City, 518109,China. Of the 24,371,872 shares of our common stock entitled to vote at the meeting, 22,089,006 shares, or 91%, were represented at the meeting in person or by proxy, constituting a quorum. The voting results are presented below.
Our shareholders elected the five nominees below to hold office until the 2013 annual meeting of shareholders or until their successors are elected and qualified. Each of the nominees received more than a majority of the votes cast. The votes regarding the election of directors were as follows:
Nominee | | For | | Authority Withheld | | Broker Non-Votes |
| | | | | | | |
| Jianquan Li | 19,351,878 | 6,739 | 2,730,389 |
| Xiuyuan Fang | 19,351,478 | 7,139 | 2,730,389 |
| Wenzhao Liang | 19,351,971 | 6,646 | 2,730,389 |
| Lawrence Xiaoxia Pan | 19,352,471 | 6,146 | 2,730,389 |
| Xuedong Wu | 19,351,971 | 6,646 | 2,730,389 |
| | 2. | Ratification and Approval of the Appointment of Independent Auditor |
The appointment of BDO China Shu Lun Pan Certified Public Accountants LLP as the Company’s independent auditor for the fiscal year ending September 30, 2012 was ratified and approved by the following votes:
For | | Against | | Abstained | |
| | | | | | |
| 3,772,745 | 43,786 | 44,651 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | Winner Medical Group Inc. |
| | |
| Date: April 20, 2012 | By: | /s/Jianquan Li |
| | | Jianquan Li
President and Chief Executive Officer |
